Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2008

01-02-2008

Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore

Auteurs: Nan Luo, Boon-Kheng Seng, Feng Xie, Shu-Chuen Li, Julian Thumboo

Gepubliceerd in: Quality of Life Research | Uitgave 1/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

To assess the psychometric properties of the Schizophrenia Quality of Life Scale (SQLS) in Asians with schizophrenia in Singapore.

Methods

A consecutive sample of outpatients with schizophrenia completed the English or Chinese version of the SQLS and the Short-Form 36 Health Survey (SF-36) twice during two different clinic visits. The patients were also assessed for presence or absence of 22 psychiatric symptoms.

Results

About 202 patients (English-speaking: 140) participated in the study. Correlations between SQLS scales and other measures assessing similar constructs ranged from 0.46 to 0.69 (P < 0.001 for all). For SQLS psychosocial and symptoms/side effects scales, item-to-scale correlations were >0.4, Cronbach’s alpha and intra-class correlation coefficient values were close to or exceed 0.7, and Cohen’s effect size, standardized response mean, and Guyatt’s responsiveness index values approximated or exceeded 0.2 for both SQLS language versions; however, for the energy/motivation scale, item-to-scale correlations (range: 0.08–0.51), reliability (range: 0.46–0.66) and responsiveness (range: 0.04–0.08) statistics were not satisfactory for both SQLS versions.

Conclusions

The SQLS psychosocial and symptoms/side effects scales are valid, reliable and responsive in Singaporean patients with schizophrenia; the appropriateness of energy/motivation scale requires further investigation.
Literatuur
1.
go back to reference Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2, e141. Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2, e141.
2.
go back to reference Pinikahana, J., Happell, B., Hope, J., & Keks, N. A. (2002). Quality of life in schizophrenia: A review of the literature from 1995 to 2000. International Journal of Mental Health Nursing, 11, 103–111.PubMedCrossRef Pinikahana, J., Happell, B., Hope, J., & Keks, N. A. (2002). Quality of life in schizophrenia: A review of the literature from 1995 to 2000. International Journal of Mental Health Nursing, 11, 103–111.PubMedCrossRef
3.
go back to reference Bobes, J., Garcia-Portilla, P., Saiz, P. A., Bascaran, T., & Bousono, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), 313–317.CrossRef Bobes, J., Garcia-Portilla, P., Saiz, P. A., Bascaran, T., & Bousono, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), 313–317.CrossRef
4.
go back to reference Hewitt, J. (2007). Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia. International Journal of Mental Health Nursing, 16, 2–14.PubMedCrossRef Hewitt, J. (2007). Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia. International Journal of Mental Health Nursing, 16, 2–14.PubMedCrossRef
5.
go back to reference Katschnig, H. (2000). Schizophrenia and quality of life. Acta Psychiatrica Scandinavica, 102, 33–37.CrossRef Katschnig, H. (2000). Schizophrenia and quality of life. Acta Psychiatrica Scandinavica, 102, 33–37.CrossRef
6.
go back to reference Guyatt, G. H., Jaeschke, R., Feeny, D. H., & Patrick, D. L. (1996). Measurement in clinical trials: Choosing the right approach. In Spilker B. (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 41–48). Philadelphia: Lippincott-Raven Publishers. Guyatt, G. H., Jaeschke, R., Feeny, D. H., & Patrick, D. L. (1996). Measurement in clinical trials: Choosing the right approach. In Spilker B. (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 41–48). Philadelphia: Lippincott-Raven Publishers.
7.
go back to reference Osoba, D. (1998). Guidelines for measuring health-related quality of life in clinical trials. In Staquet M. J., Hays R. D., & Fayers P. M. (Eds.), Quality of life assessment in clinical trials methods and practice (pp. 19–35). Oxford: Oxford University Press. Osoba, D. (1998). Guidelines for measuring health-related quality of life in clinical trials. In Staquet M. J., Hays R. D., & Fayers P. M. (Eds.), Quality of life assessment in clinical trials methods and practice (pp. 19–35). Oxford: Oxford University Press.
8.
go back to reference Awad, A. G. (1992). Quality of life of schizophrenic patients on medications and implications for new drug trials. Hospital & Community Psychiatry, 43, 262–265. Awad, A. G. (1992). Quality of life of schizophrenic patients on medications and implications for new drug trials. Hospital & Community Psychiatry, 43, 262–265.
9.
go back to reference Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10, 388–398.PubMed Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10, 388–398.PubMed
10.
go back to reference Skantze, K., Malm, U., Dencker, S. J., May, P. R., & Corrigan, P. (1992). Comparison of quality of life with standard of living in schizophrenic out-patients. British Journal of Psychiatry, 161, 797–801.PubMedCrossRef Skantze, K., Malm, U., Dencker, S. J., May, P. R., & Corrigan, P. (1992). Comparison of quality of life with standard of living in schizophrenic out-patients. British Journal of Psychiatry, 161, 797–801.PubMedCrossRef
11.
go back to reference Oliver, J., Huxley, P., Bridges, K., & Kaiser, W. (1996). Quality of life and mental health services. London: Routledge. Oliver, J., Huxley, P., Bridges, K., & Kaiser, W. (1996). Quality of life and mental health services. London: Routledge.
12.
go back to reference Lehman, A. F., Ward, N. C., & Linn, L. S. (1982). Chronic mental patients: The quality of life issue. American Journal of Psychiatry, 139, 1271–1276.PubMed Lehman, A. F., Ward, N. C., & Linn, L. S. (1982). Chronic mental patients: The quality of life issue. American Journal of Psychiatry, 139, 1271–1276.PubMed
13.
go back to reference Wilkinson, G., Hesdon, B., Wild, D., Cookson, R., Farina, C., & Sharma, V., et al. (2000). Self-report quality of life measure for people with schizophrenia: The SQLS. British Journal of Psychiatry, 177, 42–46.PubMedCrossRef Wilkinson, G., Hesdon, B., Wild, D., Cookson, R., Farina, C., & Sharma, V., et al. (2000). Self-report quality of life measure for people with schizophrenia: The SQLS. British Journal of Psychiatry, 177, 42–46.PubMedCrossRef
14.
go back to reference Kaneda, Y., Imakura, A., Fujii, A., & Ohmori, T. (2002). Schizophrenia Quality of Life Scale: Validation of the Japanese version. Psychiatry Research, 113, 107–113.PubMedCrossRef Kaneda, Y., Imakura, A., Fujii, A., & Ohmori, T. (2002). Schizophrenia Quality of Life Scale: Validation of the Japanese version. Psychiatry Research, 113, 107–113.PubMedCrossRef
15.
go back to reference Guillemin, F., Bombardier, C., & Beaton, D. (1993). Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. Journal of Clinical Epidemiology, 46, 1417–1432.PubMedCrossRef Guillemin, F., Bombardier, C., & Beaton, D. (1993). Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. Journal of Clinical Epidemiology, 46, 1417–1432.PubMedCrossRef
16.
go back to reference Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. New York: New England Medical Center. Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. New York: New England Medical Center.
17.
go back to reference Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 Health Survey. Lincoln: QualityMetric Inc. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 Health Survey. Lincoln: QualityMetric Inc.
18.
go back to reference Thumboo, J., Fong, K. Y., Machin, D., Chan, S. P., Leong, K. H., & Feng, P. H., et al. (2001). A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore. Quality of Life Research, 10, 175–188.PubMedCrossRef Thumboo, J., Fong, K. Y., Machin, D., Chan, S. P., Leong, K. H., & Feng, P. H., et al. (2001). A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore. Quality of Life Research, 10, 175–188.PubMedCrossRef
19.
go back to reference Wilkinson, G., Wild, D., Fitzpatrick, R., Jenkinson, C., & Hesdon, B. (1999). User manual for the SQLS. Headington: Oxford Outcomes. Wilkinson, G., Wild, D., Fitzpatrick, R., Jenkinson, C., & Hesdon, B. (1999). User manual for the SQLS. Headington: Oxford Outcomes.
20.
go back to reference Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., & Kinsella, A., et al. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.PubMedCrossRef Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., & Kinsella, A., et al. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.PubMedCrossRef
21.
go back to reference Meltzer, H. Y., Burnett, S., Bastani, B., & Ramirez, L. F. (1990). Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hospital & Community Psychiatry, 41, 892–897. Meltzer, H. Y., Burnett, S., Bastani, B., & Ramirez, L. F. (1990). Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hospital & Community Psychiatry, 41, 892–897.
22.
go back to reference Juniper, E. F., Gordon, H. G., & Roman, J. (1996). How to develop and validate a new health-related quality of life instrument. In Spilker B. (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 49–56). Philadelphia: Lippincott-Raven Publishers. Juniper, E. F., Gordon, H. G., & Roman, J. (1996). How to develop and validate a new health-related quality of life instrument. In Spilker B. (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 49–56). Philadelphia: Lippincott-Raven Publishers.
23.
go back to reference Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Chichester: John Wiley & Sons. Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Chichester: John Wiley & Sons.
24.
go back to reference Hays, R. D., Anderson, R. T., & Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In Staquet M. J., Hays R. D., & Fayers P. M. (Eds.), Quality of Life assessssment in clinical trials methods and practice (pp. 169–182). Oxford: Oxford University Press. Hays, R. D., Anderson, R. T., & Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In Staquet M. J., Hays R. D., & Fayers P. M. (Eds.), Quality of Life assessssment in clinical trials methods and practice (pp. 169–182). Oxford: Oxford University Press.
25.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Earlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Earlbaum Associates.
26.
go back to reference Deyo, R. A., Diehr, P., & Patrick, D. L. (1991). Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials, 12, 142S–158S.PubMedCrossRef Deyo, R. A., Diehr, P., & Patrick, D. L. (1991). Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials, 12, 142S–158S.PubMedCrossRef
27.
go back to reference Guyatt, G., Walter, S., & Norman, G. (1987). Measuring change over time: Assessing the usefulness of evaluative instruments. Journal of Chronic Diseases, 40, 171–178.PubMedCrossRef Guyatt, G., Walter, S., & Norman, G. (1987). Measuring change over time: Assessing the usefulness of evaluative instruments. Journal of Chronic Diseases, 40, 171–178.PubMedCrossRef
28.
go back to reference Schunemann, H. J., & Guyatt, G. H. (2005). Commentary—goodbye M(C)ID! Hello MID, where do you come from? Health Services Research, 40, 593–597.PubMedCrossRef Schunemann, H. J., & Guyatt, G. H. (2005). Commentary—goodbye M(C)ID! Hello MID, where do you come from? Health Services Research, 40, 593–597.PubMedCrossRef
29.
go back to reference Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.PubMed Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.PubMed
30.
go back to reference Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812.CrossRef Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812.CrossRef
31.
go back to reference Peto, V., Jenkinson, C., & Fitzpatrick, R. (2001). Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing, 30, 299–302.PubMedCrossRef Peto, V., Jenkinson, C., & Fitzpatrick, R. (2001). Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing, 30, 299–302.PubMedCrossRef
32.
go back to reference Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Quality of Life and Outcomes, 1, 4. Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Quality of Life and Outcomes, 1, 4.
Metagegevens
Titel
Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore
Auteurs
Nan Luo
Boon-Kheng Seng
Feng Xie
Shu-Chuen Li
Julian Thumboo
Publicatiedatum
01-02-2008
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 1/2008
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9278-1

Andere artikelen Uitgave 1/2008

Quality of Life Research 1/2008 Naar de uitgave